Sofinnova Investments, Inc. Q1 2021 Filing
Filed May 14, 2021
Portfolio Value
$1.7T
Holdings
64
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (64 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera | 3,100,560 | $314.8B | 18.93% | |
| 2 | KRTXKaruna Therapeutics, Inc. | 1,952,441 | $234.7B | 14.11% | |
| 3 | BOLT1EURBolt Biotherapeutics, Inc. | 2,754,437 | $90.6B | 5.45% | |
| 4 | ASNDAscendis Pharma A/S | 521,923 | $67.3B | 4.04% | |
| 5 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $66.4B | 3.99% | |
| 6 | AZNAstraZeneca PLC | 1,035,732 | $51.5B | 3.10% | |
| 7 | XLFIHealth Care Select Sector SPDR | 400,000 | $46.7B | 2.81% | Put |
| 8 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $43.8B | 2.63% | |
| 9 | JAZZJazz Pharmaceuticals PLC | 255,928 | $42.1B | 2.53% | |
| 10 | INZYInozyme Pharma, Inc. | 2,028,308 | $40.2B | 2.41% | |
| 11 | UTHUnited Therapeutics Corp | 215,054 | $36.0B | 2.16% | |
| 12 | LLYEli Lilly and Co | 180,501 | $33.7B | 2.03% | |
| 13 | —Nucana Biomed Ltd | 5,599,999 | $27.9B | 1.68% | |
| 14 | MRUSMerus N.V. | 1,311,039 | $27.4B | 1.65% | |
| 15 | GRTXGalera Therapeutics, Inc | 3,083,712 | $27.2B | 1.64% | |
| 16 | NXTCNextcure, Inc | 2,671,856 | $26.7B | 1.61% | |
| 17 | AFWAlign Technology Inc | 45,500 | $24.6B | 1.48% | |
| 18 | XLRNAcceleron Pharma Inc | 178,538 | $24.2B | 1.46% | |
| 19 | RETAEURReata Pharmaceuticals Inc | 238,520 | $23.8B | 1.43% | |
| 20 | MRTXEURMirati Therapeutics Inc | 138,030 | $23.6B | 1.42% | |
| 21 | ITCIEURIntra-Cellular Therapies Inc | 655,001 | $22.2B | 1.34% | |
| 22 | PTCTPTC Therapeutics Inc | 466,840 | $22.1B | 1.33% | |
| 23 | IM8NInsmed Inc | 618,950 | $21.1B | 1.27% | |
| 24 | —Akouos, Inc | 1,515,074 | $21.0B | 1.26% | |
| 25 | GILDGilead Sciences Inc | 300,000 | $19.4B | 1.17% | Call |
| 26 | EX9Exelixis Inc | 839,181 | $19.0B | 1.14% | |
| 27 | PTGXProtagonist Therapeutics Inc | 654,900 | $17.0B | 1.02% | |
| 28 | —ObsEva SA | 4,749,623 | $15.4B | 0.93% | |
| 29 | QUREUniqure NV | 427,122 | $14.4B | 0.87% | |
| 30 | RGNXRegenxbio Inc | 361,735 | $12.3B | 0.74% | |
| 31 | HZNPHorizon Therapeutics PLC | 133,997 | $12.3B | 0.74% | |
| 32 | —Nucana Biomed Ltd | 2,400,000 | $12.0B | 0.72% | |
| 33 | VRTXVertex Pharmaceuticals Inc | 45,700 | $9.8B | 0.59% | |
| 34 | DC4Dexcom Inc | 27,000 | $9.7B | 0.58% | |
| 35 | AMGNAmgen Inc | 38,868 | $9.7B | 0.58% | |
| 36 | AGENEURAgenus Inc | 3,478,201 | $9.5B | 0.57% | |
| 37 | MIRMMirum Pharmaceuticals Inc | 476,401 | $9.4B | 0.57% | |
| 38 | —Athira Pharma, Inc. | 509,168 | $9.4B | 0.56% | |
| 39 | CCXIEURChemoCentryx Inc | 179,999 | $9.2B | 0.55% | |
| 40 | CYTKCytokinetics Inc | 389,720 | $9.1B | 0.54% | |
| 41 | —ChemoCentryx Inc | 150,000 | $7.7B | 0.46% | Put |
| 42 | —TCR2 Therapeutics Inc | 336,682 | $7.4B | 0.45% | |
| 43 | AMRNAmarin Corp | 1,170,584 | $7.3B | 0.44% | |
| 44 | SNDXSyndax Pharmaceuticals Inc | 298,644 | $6.7B | 0.40% | |
| 45 | CHRSCoherus BioSciences | 434,555 | $6.3B | 0.38% | |
| 46 | ARNAEURArena Pharmaceuticals Inc | 91,448 | $6.3B | 0.38% | |
| 47 | MRNS*Marinus Pharmaceuticals Inc | 370,351 | $5.7B | 0.34% | |
| 48 | JNCEEURJounce Therapeutics Inc | 511,822 | $5.3B | 0.32% | |
| 49 | PODDInsulet Corp | 17,500 | $4.6B | 0.27% | |
| 50 | FATEFate Therapeutics Inc | 54,795 | $4.5B | 0.27% | |
| 51 | REPLReplimune Group Inc | 142,209 | $4.3B | 0.26% | |
| 52 | IMTXImmatics NV | 385,099 | $4.3B | 0.26% | |
| 53 | ALGSAligos Therapeutics Inc | 185,532 | $4.2B | 0.25% | |
| 54 | —Aptose Biosciences Inc | 696,928 | $4.2B | 0.25% | |
| 55 | HRTXHeron Therapeutics Inc | 250,000 | $4.1B | 0.24% | Call |
| 56 | BCRXBioCryst Pharmaceuticals Inc | 378,774 | $3.9B | 0.23% | |
| 57 | YB4PSavara Inc | 1,737,450 | $3.6B | 0.22% | |
| 58 | PBYIPuma Biotechnology Inc | 344,917 | $3.4B | 0.20% | |
| 59 | OTICEUROtonomy Inc | 1,251,256 | $3.2B | 0.19% | |
| 60 | KURAKura Oncology Inc | 83,164 | $2.4B | 0.14% | |
| 61 | MGNXMacroGenics Inc | 73,201 | $2.3B | 0.14% | |
| 62 | —Synlogic Inc. | 574,972 | $2.1B | 0.12% | |
| 63 | —Calithera Biosciences Inc | 757,533 | $1.8B | 0.11% | |
| 64 | PDSBPDS Biotechnology Corporation | 142,635 | $649.0M | 0.04% |